| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Roderick MacKinnon last filed a Form 4 in July 2017, as Director at DCOY. Roderick MacKinnon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 431,277 shares of DCOY. Net of sales, the DCOY filings show accumulation of 10,000 shares.
Roderick MacKinnon has 4 Form 4 filings on record from June 2015 to July 2017, all as Director at Salarius Pharmaceuticals (DCOY), 2015–2017.
The 4 reported transactions were 3 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $70K and no sales.
The only open-market purchase was 10,000 shares of DCOY at an average $7.03 on March 11, 2016, about $70K.
Shares as reported in the last Form 4 for each company; the most recent is from July 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2016 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 10,000 | $7.03 | $70,261.00 | +2.4% |